Reports
-
Pharmaceutical innovation, incremental patenting and compulsory licensing
Despite the decline in the discovery of new chemical entities for pharmaceutical use, there is a significant proliferation of patents on products and processes that cover minor, incremental innovations.
Published date
Sunday, January 2, 2011 - 00:00